Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Kos, S. Aksoy, H. Odabas, N. Ozdemir, B. Oksuzoglu, D. Uncu, N. Zengi̇n (2011)
Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study.Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 16 3
C. Anderson, Michael Rice, C. Pinson, W. Chapman, R. Chari, D. Delbeke (2007)
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinomaJournal of Gastrointestinal Surgery, 8
A. Maldonado, F. González-Alenda, M. Alonso, J. Sierra (2007)
PET-CT in clinical oncologyClinical and Translational Oncology, 9
Hua Meng, Xin Wang, Y. Fong, Zihao Wang, Yu Wang, Zhong-tao Zhang (2011)
Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases.Japanese journal of clinical oncology, 41 8
Jahae Kim, S. Yoo, Sae-Ryung Kang, Sang-Geon Cho, Jong-Ryool Oh, A. Chong, J. Min, H. Bom, Jung-han Yoon, Ho-Chun Song (2012)
Prognostic Significance of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Operable Primary Breast CancerNuclear Medicine and Molecular Imaging, 46
Ai Oe, J. Kawabe, Kenji Torii, E. Kawamura, Jin Kotani, Takehiro Hayashi, Hiroko Kurooka, S. Shiomi, Chikako Tsumoto, S. Higashiyama, S. Kubo (2006)
Distinguishing benign from malignant gallbladder wall thickening using FDG-PETAnnals of Nuclear Medicine, 20
(2012)
CT in operable primary breast cancer
Seung Lee, Hong-Joo Kim, J. Park, D. Park, Y. Cho, C. Sohn, W. Jeon, B. Kim (2010)
Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinomaJournal of Gastroenterology, 45
(2002)
uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small-cell lung cancer
(2002)
18 F - FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non - small - cell lung cancer
J. Butte, F. Redondo, E. Waugh, M. Meneses, R. Pruzzo, Hugo Parada, H. Amaral, H. Fuente (2009)
The role of PET-CT in patients with incidental gallbladder cancer.HPB : the official journal of the International Hepato Pancreato Biliary Association, 11 7
S. Kim, K. Won, B. Choi, I. Jo, S. Zeon, W. Chung, J. Kwon (2012)
Usefulness of F-18 FDG PET/CT in the Evaluation of Early Treatment Response After Interventional Therapy for Hepatocellular CarcinomaNuclear Medicine and Molecular Imaging, 46
A. Sacks, P. Peller, D. Surasi, L. Chatburn, G. Mercier, R. Subramaniam (2011)
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.AJR. American journal of roentgenology, 197 2
(2002)
F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small-cell lung cancer
K. Shibata, H. Uchida, K. Iwaki, S. Kai, M. Ohta, S. Kitano (2009)
Lymphatic Invasion: An Important Prognostic Factor for Stages T1b–T3 Gallbladder Cancer and an Indication for Additional Radical Resection of Incidental Gallbladder CancerWorld Journal of Surgery, 33
Jang Yoo, J. Choi, Kyu Lee, J. Heo, Soo Park, S. Moon, Y. Choe, Kyung-Han Lee, Byung‐Tae Kim (2012)
Prognostic Significance of Volume-based Metabolic Parameters by 18F-FDG PET/CT in Gallbladder CarcinomaNuclear Medicine and Molecular Imaging, 46
Rakesh Kumar, P. Sharma, A. Kumari, D. Halanaik, A. Malhotra (2012)
Role of 18F-FDG PET/CT in Detecting Recurrent Gallbladder CarcinomaClinical Nuclear Medicine, 37
A. Hezel, A. Zhu (2008)
Systemic therapy for biliary tract cancers.The oncologist, 13 4
S. Cho, S. Kim, Sang-Jae Park, Sung-Sik Han, Young‐Kyu Kim, Kwang-Wonng Lee, Woojin Lee, S. Woo, Tae‐Hyun Kim (2010)
Adjuvant chemoradiation therapy in gallbladder cancerJournal of Surgical Oncology, 102
John Donohue (2001)
Present status of the diagnosis and treatment of gallbladder carcinoma.Journal of hepato-biliary-pancreatic surgery, 8 6
S. Chan, R. Poon, C. Lo, K. Ng, S. Fan (2008)
Management of carcinoma of the gallbladder: A single‐institution experience in 16 yearsJournal of Surgical Oncology, 97
(2014)
Nucl Med Mol Imaging
C. Corvera, L. Blumgart, T. Akhurst, R. DeMatteo, M. D'Angelica, Y. Fong, W. Jarnagin (2008)
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.Journal of the American College of Surgeons, 206 1
H. Furukawa, H. Ikuma, K. Asakura, K. Uesaka (2009)
Prognostic importance of standardized uptake value on F‐18 fluorodeoxyglucose‐positron emission tomography in biliary tract carcinomaJournal of Surgical Oncology, 100
(2011)
Prognostic value of 18 F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer
(2006)
Impact of integrated positron emission tomography on staging and management of gallbladder cancer and cholangiocarcinoma
Prognostic significance of metabolic tumor
K. Ouchi, Y. Owada, S. Matsuno, T. Sato (1987)
Prognostic factors in the surgical treatment of gallbladder carcinoma.Surgery, 101 6
(1999)
Long-term survival of patients with biliary tract cancer with lymph node involvement
Nucl Med Mol Imaging (2014) 48:114–120 DOI 10.1007/s13139-013-0255-z ORIGINAL ARTICLE Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer Jae Pil Hwang & Ilhan Lim & Im II Na & Eung Ho Cho & Byung II Kim & Chang Woon Choi & Sang Moo Lim Received: 11 April 2013 /Revised: 16 November 2013 /Accepted: 20 November 2013 /Published online: 6 December 2013 Korean Society of Nuclear Medicine 2013 Abstract 0.0400). On Kaplan-Meier analysis, SUVmax (p =0.0400), Objective The aim of this study is to investigate the prognos- stage (p =0.0001), CA19-9 (p =0.013), CEA (p =0.006), LN tic value of F-18 fluorodeoxyglucose (F-18 FDG) positron metastasis (p =0.0001), distant metastasis (p =0.0020), type of emission tomography (PET)/computed tomography (CT) in treatment (p =0.0001) were significantly associated with over- gallbladdercancerpatients. all survival. Multivariate analysis study revealed that the Methods From June 2004 to June 2010, a total of 50 patients patients with lower SUVmax measured from initial staging with gallbladder cancer who underwent diagnostic staging PET/CT (p =0.0380), no LN metastasis (p =0.0260), a lower with F-18 FDG PET/CT following curative or palliative treat- stage (p =0.026) and curative treatment
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Dec 6, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.